Anti-FGF-2
Anti-Fibroblast Growth Factor, Basic
Anti-HBGF-1
Anti-Heparin Binding Growth Factor

Host: Mouse

Isotype: IgG1

Immunogen: recombinant human bFGF

Form: Lyophilized

Formulation: Lyophilized from PBS, 0.1% BSA.

Preservative: ≤0.1% sodium azide

Comments: Detects the ~18 kDa bFGF. No cross-reactivity with aFGF. No pretreatment needed for paraffin sections. This antibody neutralizes the bioactivity of bFGF. Sold under license of U.S. Patent 5,478,740, European Patent 0,288,687, and Japanese Patent 2,526,965.

Ref.: Takami, K., et al. 1992 Exp. Brain Res. 90, 1. Watanabe, H., et al. 1991 Biochem. Biophys. Res. Com. 175, 229. Fiege, J.J. and Baird, A. 1989. Proc. Natl. Acd. Sci. USA 86, 3174. Florkiewicz, R.Z. and Sommer, A. 1989. Proc. Natl. Acd. Sci. USA 86, 3978. Rifkin, D.B. and Moscatelli, D. 1989. J. Cell Biol. 109, 1. Baird, A., et al. 1988 Proc. Natl. Acad. Sci. USA 85, 2324. Chodak, G.W., et al. 1988. Cancer Res. 48, 2083. Moscatelli, D., et al. 1987. Proc. Natl. Acd. Sci. USA 84, 5778. Sommer, A., et al. 1987 Biochem. Biophy. Res. Com. 144, 543. Abraham, J.A., et al. 1986 EMBO J. 5, 2523. Esch, F., et al. 1985 Proc. Natl. Acad. Sci. USA 82, 6507. Knighton, D., et al. 1977. J. Cancer 35, 347.

Sold under license of U.S. Patent 5,478,740, European Patent 0,288,687, and Japanese Patent 2,526,965.